Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Sexual function following radical prostatectomy: a prospective longitudinal study of cultural differences between Japanese and American men

Abstract

We conducted a cross-cultural comparison of the recovery of sexual function and bother during the first 2 years after radical prostatectomy (RP) between American and Japanese men. A total of 275 Japanese and 283 American men who underwent RP alone were prospectively enrolled into longitudinal cohort studies of health-related quality of life outcomes. Sexual function and bother (distress) were estimated with English and validated Japanese versions of the UCLA Prostate Cancer Index before RP and 1, 2–3, 4–6, 12, 18 and 24 months after RP. Each subject served as his own control. Japanese men reported lower sexual function scores at baseline, even after adjusted for age, prostate-specific antigen (PSA) and comorbidity (38 vs 61, P<0.001). The two groups had similar baseline sexual bother (70 vs 69, P=0.84). Japanese men had a smaller improvement in sexual function (β=0.8 vs β=5.3) and bother (β=0.2 vs β=2.9) over time than did the American men postoperatively, after adjusting for baseline score, age, baseline PSA and nerve-sparing. American men were more likely than Japanese men to regain their baseline sexual function by 24 months after surgery (hazard ratio (HR)=1.60; 95% confidence interval (CI)=1.06–2.42). In contrast, American men were less likely than Japanese men to return to baseline sexual bother (HR=0.57; 95% CI=0.44–0.75). This study demonstrates that Japanese and American men experience different patterns of recovery of their sexual function and bother after RP. Ethnicity may be a contributing factor.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977–1984.

    Article  CAS  PubMed  Google Scholar 

  2. Nicolosi A, Moreira Jr ED, Shirai M, Bin Mohd Tambi MI, Glasser DB . Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003; 61: 201–206.

    Article  PubMed  Google Scholar 

  3. Johnson TK, Gilliland FD, Hoffman RM, Deapen D, Penson DF, Stanford JL et al. Racial/ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. J Clin Oncol 2004; 22: 4193–4201.

    Article  PubMed  Google Scholar 

  4. Litwin MS, Hays RD, Fink A, Ganz PG, Leake B, Brook RH . The UCLA prostate cancer index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 1002–1012.

    Article  CAS  PubMed  Google Scholar 

  5. Kakehi Y, Kamoto T, Ogawa O, Arai Y, Litwin MS, Suzukamo Y et al. Development of Japanese version of the UCLA prostate cancer index: a pilot validation study. Int J Clin Oncol 2002; 7: 306–311.

    PubMed  Google Scholar 

  6. Masumori N, Tsukamoto T, Kumamoto Y, Panser LA, Rhodes T, Girman CJ et al. Decline of sexual function with age in Japanese men compared with American men—results of two community-based studies. Urology 1999; 54: 335–344.

    Article  CAS  PubMed  Google Scholar 

  7. Miller DC, Wei JT, Dunn RL, Montie JE, Pimentel H, Sandler HM et al. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference. Urology 2006; 68: 166–171.

    Article  PubMed  Google Scholar 

  8. Gralnek D, Wessells H, Cui H, Dalkin BL . Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology 2000; 56: 641–646.

    Article  PubMed  Google Scholar 

  9. Moreira Jr ED, Brock G, Glasser DB, Nicolosi A, Laumann EO, Paik A et al. Help-seeking behaviour for sexual problems: the global study of sexual attitudes and behaviors. Int J Clin Pract 2005; 59: 6–16.

    Article  PubMed  Google Scholar 

  10. Hisasue S, Kumamoto Y, Sato Y, Masumori N, Horita H, Kato R et al. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: a Japanese female cohort study. Urology 2005; 65: 143.

    Article  PubMed  Google Scholar 

  11. Stephenson RA, Mori M, Hsieh YC, Beer TM, Stanford JL, Gilliland FD et al. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the surveillance, epidemiology, and end results prostate cancer outcomes study. J Urol 2005; 174: 646–650.

    Article  PubMed  Google Scholar 

  12. Nicolosi A, Glasser DB, Kim SC, Marumo K, Laumann EO, GSSAB investigators' group. Sexual behaviour and dysfunction and help-seeking patterns in adults aged 40–80 years in the urban population of Asian countries. BJU Int 2005; 95: 609–614.

    Article  PubMed  Google Scholar 

  13. Shabsigh R, Perelman MA, Laumann EO, Lockhart DC . Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries. BJU Int 2004; 94: 1055–1065.

    Article  PubMed  Google Scholar 

  14. Namiki S, Saito S, Satoh M, Ishidoya S, Kawamura S, Tochigi T et al. Quality of life after radical prostatectomy in Japanese men: 2 year longitudinal study. Jpn J Clin Oncol 2005; 35: 551–558.

    Article  PubMed  Google Scholar 

  15. Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C et al. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer 2002; 95: 2397–2407.

    Article  PubMed  Google Scholar 

  16. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 1997; 158: 1408–1410.

    Article  CAS  PubMed  Google Scholar 

  17. Mulhall J, Land S, Parker M . The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005; 2: 532–540.

    Article  CAS  PubMed  Google Scholar 

  18. Litwin MS, Melmed GY, Nakazon T . Life after radical prostatectomy: a longitudinal study. J Urol 2001; 166: 587–592.

    Article  CAS  PubMed  Google Scholar 

  19. Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, Deapen D et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 2003; 21: 1147–1154.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M S Litwin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Namiki, S., Kwan, L., Kagawa-Singer, M. et al. Sexual function following radical prostatectomy: a prospective longitudinal study of cultural differences between Japanese and American men. Prostate Cancer Prostatic Dis 11, 298–302 (2008). https://doi.org/10.1038/sj.pcan.4501013

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4501013

Keywords

This article is cited by

Search

Quick links